Summary & Overview
CPT 83789: Mass Spectrometry Testing for Nondrug Analytes
CPT code 83789 designates the technical laboratory procedure for detecting or quantifying a nondrug analyte using mass spectrometry and tandem mass spectrometry. As an advanced clinical laboratory service, it supports diagnostic workflows across specialties that require precise measurement of biochemical markers, toxicology screens, metabolic testing, and other nonpharmaceutical analytes. Nationally, codes like 83789 matter because they underpin access to specialized testing, drive laboratory billing practices, and inform payer coverage and reimbursement policies for high-complexity assays.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, the clinical and laboratory context for use, typical sites of service, and which major payers are relevant to coverage discussions. The publication also summarizes available benchmarks and policy considerations for mass spectrometry–based nondrug analyte testing where data is available. Where specific input data is missing, the text notes that those items are not available in the input rather than inferring details.
This executive summary prepares clinicians, laboratory managers, and policy analysts to interpret billing practices related to 83789, understand payer relevance at a national level, and locate further detail on technical, clinical, and administrative aspects of mass spectrometry laboratory services.
Billing Code Overview
CPT code 83789 describes a laboratory analytical procedure in which a lab analyst performs the technical testing to evaluate a specimen for the presence or amount of a nondrug analyte using mass spectrometry and tandem mass spectrometry. This code identifies the technical component of a mass spectrometry–based assay focused on quantifying or detecting chemical analytes that are not pharmaceutical agents.
-
Service type: Clinical laboratory testing using mass spectrometry/tandem mass spectrometry
-
Typical site of service: Clinical laboratory or hospital laboratory performing specialized analytical testing
Clinical & Coding Specifications
Clinical Context
A typical scenario involves an outpatient or hospital-based clinical laboratory receiving a blood, urine, or other biological specimen for quantitative analysis of a nondrug analyte using mass spectrometry and tandem mass spectrometry. A pediatric metabolic clinic orders the test for a newborn screening follow-up after an abnormal heel-stick screen; the sample is sent to a reference lab. A clinical chemistry technologist or medical laboratory scientist performs specimen preparation, internal standard addition, chromatographic separation if applicable, and analysis on a tandem mass spectrometer. The analytic phase includes calibration, quality controls, peak identification, quantitation, and result verification. The laboratory issues a final report to the ordering provider (e.g., pediatrician, metabolic specialist, or hospitalist) documenting measured concentrations and interpretive comments. Typical workflow steps: clinician orders test in the electronic medical record; specimen collected and sent with appropriate requisition; lab accessioning and specimen processing; mass spectrometry/tandem mass spectrometry analysis by the technical staff; result validation and release; clinician reviews results and documents follow-up plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing physician or qualified pathologist interprets results or provides professional interpretation separate from the performing lab technical component |